| 2024 | Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer | CANCER RESEARCH |
| 2023 | Secondary cytoreductive surgery with and without hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer
| GLAND SURGERY |
| 2023 | Hyperthermic Intraperitoneal Chemotherapy After Interval Cytoreductive Surgery for Patients With Advanced-Stage Ovarian Cancer Who Had Received Neoadjuvant Chemotherapy | JAMA SURGERY |
| 2023 | Frequency of peripheral PD-1+regulatory T cells is associated with treatment responses to PARP inhibitor maintenance in patients with epithelial ovarian cancer | BRITISH JOURNAL OF CANCER |
| 2023 | Comparison of oncological outcomes between sentinel lymph node biopsy and complete lymphadenectomy for endometrial cancer | JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH |
| 2023 | Investigation of PARP Inhibitor Resistance Based on Serially Collected Circulating Tumor DNA in Patients With BRCA-Mutated Ovarian Cancer | CLINICAL CANCER RESEARCH |
| 2023 | Comparing surgical outcomes of da Vinci SP and da Vinci Xi for endometrial cancer surgical staging in a propensity score-matched study
| SCIENTIFIC REPORTS |
| 2023 | Comprehensive genomic and immunohistochemical profiles and outcomes of immunotherapy in patients with recurrent or advanced cervical cancer
| FRONTIERS IN ONCOLOGY |
| 2023 | Role of diagnostic laparoscopy in deciding primary treatment in advanced-stage ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2022 | USEFULNESS OF PRE-OPERATIVE PET-CT IN PATIENTS WITH ENDOMETRIAL CANCER UNDERGOING SENTINEL LYMPH NODE MAPPING: DO NEGATIVE FINDINGS ON PET-CT NEGATIVITY REALLY INDICATE NODE NEGATIVITY? | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | RE-VALIDATION OF CHEMOTHERAPY RESPONSE SCORE (CRS) AS A PROGNOSTIC FACTOR IN OVARIAN CANCER: THE EFFECT OF BEVACIZUMAB AND HIPEC ON SURVIVAL | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | PROPENSITY SCORE-MATCHED COMPARISON OF PERIOPERATIVE OUTCOMES USING DA VINCI XI AND SP SURGICAL SYSTEM IN ENDOMETRIAL CANCER SURGICAL STAGING | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | PREDICTION OF SURGICAL OUTCOMES OF INTERVAL DEBULKING SURGERY (IDS) USING IN ADVANCED OVARIAN CANCER: A NOVEL SCORING SYSTEM USING POST-NEOADJUVANT CHEMOTHERAPY (NAC) COMPUTED TOMOGRAPHY (CT) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | PATIENT-DERIVED ORGANOIDS AS A PRECLINICAL PLATFORM FOR PRECISION MEDICINE IN PATIENTS WITH CERVICAL CANCER | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | OREGOVOMAB AND NON-PLATINUM SINGLE AGENT CHEMOTHERAPY IN PARP INHIBITOR-RESISTANT OVARIAN CANCER PATIENTS NOT CANDIDATE FOR PLATINUM RETREATMENT: A MULTI-COHORT PHASE II STUDY (KGOG 3065/APGOT-OV6) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | LATE-BREAKING ABSTRACT PRESENTATION: COMPARATIVE EFFECTIVENESS OF HIPEC FOLLOWING INTERVAL CYTOREDUCTIVE SURGERY IN PATIENTS WITH ADVANCED-STAGE OVARIAN CANCER UNDERGOING NEOADJUVANT CHEMOTHERAPY: MULTICENTER, PROSPECTIVE, COHORT STUDY (KGOG 3042) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-2 (HER2) RECEPTOR EXPRESSION AND ITS DYNAMIC CHANGE IN OVARIAN CANCER PATIENTS | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Expression profiles of id and E2A in ovarian cancer and sup-pression of ovarian cancer by the E2A isoform E47 | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Dynamic changes of peripheral regulatory t cells during parp inhibitor maintenance therapy in patients with ovarian cancer | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Comprehensive profiling of cervix cancer patients using tumor next-generation sequencing (NGS) and immunohistochemistry (IHC) | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Added value of sentinel lymph node biopsy in patients with negative lymph node on triple pre-operative images | INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER |
| 2022 | Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity? | GYNECOLOGIC ONCOLOGY |
| 2022 | Feasibility and clinical applicability of genomic profiling based on cervical smear samples in patients with endometrial cancer
| FRONTIERS IN ONCOLOGY |
| 2022 | Interval debulking surgery with or without hyperthermic intraperitoneal chemotherapy in advanced-stage ovarian cancer: Single-institution cohort study
| FRONTIERS IN ONCOLOGY |
| 2022 | A Phase II Trial to Evaluate the Efficacy of Bortezomib and Liposomal Doxorubicin in Patients With BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer (KGOG 3044/EBLIN)
| IN VIVO |
| 2022 | Expression Profiles of ID and E2A in Ovarian Cancer and Suppression of Ovarian Cancer by the E2A Isoform E47
| CANCERS |
| 2022 | Dynamics of the Tumor Immune Microenvironment during Neoadjuvant Chemotherapy of High-Grade Serous Ovarian Cancer
| CANCERS |
| 2022 | Incidence of postoperative thrombotic events in ovarian cancer patients with a de-escalated prophylactic strategy: A retrospective cohort study | GYNECOLOGIC ONCOLOGY |
| 2022 | Quenching Epigenetic Drug Resistance Using Antihypoxic Microparticles in Glioblastoma Patient-Derived Chips | ADVANCED HEALTHCARE MATERIALS |
| 2022 | Indocyanine green fluorescent image-guided inguinal sentinel lymph node biopsy in vulvar cancer
| Obstetrics & Gynecology Science |
| 2022 | Therapeutic Efficacy of Catheter-directed Ethanol Sclerotherapy and Its Impact on Ovarian Reserve in Patients with Ovarian Endometrioma at Risk of Decreased Ovarian Reserve: A Preliminary Study | JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY |
| 2022 | Da Vinci SP Single-Port Robotic Surgery in Gynecologic Tumors: Single Surgeon's Initial Experience with 100 Cases
| YONSEI MEDICAL JOURNAL |
| 2021 | Cancer Patient Tissueoid with Self-Homing Nano-Targeting of Metabolic Inhibitor
| ADVANCED SCIENCE |
| 2021 | Hormone autocrination by vascularized hydrogel delivery of ovary spheroids to rescue ovarian dysfunctions
| SCIENCE ADVANCES |
| 2021 | A single-arm phase II study of olaparib maintenance with pembrolizumab and bevacizumab in BRCA non-mutated patients with platinum-sensitive recurrent ovarian cancer (OPEB-01)
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2021 | Comparison of single-port laparoscopy and laparotomy in early ovarian cancer surgical staging
| Obstetrics & Gynecology Science |
| 2020 | 4-1BB co-stimulation further enhances anti-PD-1-mediated reinvigoration of exhausted CD39 + CD8 T cells from primary and metastatic sites of epithelial ovarian cancers
| JOURNAL FOR IMMUNOTHERAPY OF CANCER |
| 2020 | Real-World Experience of Pembrolizumab Monotherapy in Patients with Recurrent or Persistent Cervical Cancer: A Korean Multi-Center Retrospective Study (KGOG1041)
| CANCERS |
| 2020 | 복강경하 전자궁절제술의 예방적 항생제로 사용한 Cefotetan과 Cefotiam의 효과 비교
| Journal of Surgical Infection (대한수술감염학회지) |
| 2020 | Rethinking Radical Surgery in Interval Debulking Surgery for Advanced-Stage Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy
| JOURNAL OF CLINICAL MEDICINE |
| 2020 | Comparison between weekly versus 3-weekly paclitaxel in combination with carboplatin as neoadjuvant chemotherapy in advanced ovarian cancer
| JOURNAL OF GYNECOLOGIC ONCOLOGY |
| 2020 | Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
| BMC CANCER |
| 2020 | Hydrogel cross-linking-programmed release of nitric oxide regulates source-dependent angiogenic behaviors of human mesenchymal stem cell
| SCIENCE ADVANCES |
| 2020 | Genomic profiling of the residual disease of advanced high-grade serous ovarian cancer after neoadjuvant chemotherapy | INTERNATIONAL JOURNAL OF CANCER |
| 2020 | Catalytic microgelators for decoupled control of gelation rate and rigidity of the biological gels | JOURNAL OF CONTROLLED RELEASE |
| 2019 | Real-World Experience of Olaparib Maintenance in High-Grade Serous Recurrent Ovarian Cancer Patients with BRCA1/2 Mutation: A Korean Multicenter Study
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041) | GYNECOLOGIC ONCOLOGY |
| 2019 | Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy | EJSO |
| 2019 | Integrating a Next Generation Sequencing Panel into Clinical Practice in Ovarian Cancer
| Yonsei Medical Journal |
| 2019 | Development of a Shape-Memory Tube to Prevent Vascular Stenosis | Advanced Materials |
http://orcid.org/0000-0003-0297-3116
